Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor-Reference-Cited by-同舟云学术

Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor

Published:2021-04-25 Issue:7 Volume:19 Page:1729-1737
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Khialani Deeksha¹,Vasan Sowmya²,Cushman Mary³^ORCID,Dahm Anders Erik Astrup⁴⁵^ORCID,Sandset Per Morten⁵⁶^ORCID,Rossouw Jacques⁷,Hylckama Vlieg Astrid¹

Affiliation:

1. Department of Clinical Epidemiology Leiden University Medical Center Leiden The Netherlands

2. Fred Hutchinson Cancer Research Center Seattle WA USA

3. Department of Medicine Larner College of Medicine University of Vermont Burlington VT USA

4. Department of Haematology Akershus University Hospital Lørenskog Norway

5. Institute of Clinical Medicine University of Oslo Oslo Norway

6. Department of Haematology Oslo University Hospital Oslo Norway

7. National Heart, Lung, and Blood Institute Bethesda MD USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15319

Reference27 articles.

1. Hormone replacement therapy for preventing cardiovascular disease in post‐menopausal women;Gabriel SR;Cochrane Database Syst Rev,2005

2. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

3. Increased risk of recurrent venous thromboembolism during hormone replacement therapy–results of the randomized, double‐blind, placebo‐controlled estrogen in venous thromboembolism trial (EVTET);Høibraaten E;Thromb Haemost,2000

4. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

5. A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis;Menopause;2024-03

2. Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays;Research and Practice in Thrombosis and Haemostasis;2023-08

3. Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism;Blood Coagulation & Fibrinolysis;2023-04-13

4. Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism;Thrombosis Research;2021-11

5. The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study;Clinical and Applied Thrombosis/Hemostasis;2021-01